United States· US:55150-311_b8f27635-ad16-41d2-a667-eaf51437947a
Hydroxyprogesterone Caproate
A hydroxyprogesterone product containing hydroxyprogesterone caproate, registered in United States by AuroMedics Pharma LLC. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Hydroxyprogesterone is registered in 3 of 19 countries.
Countries holding a registration under ATC G03DA03 (hydroxyprogesterone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Hydroxyprogesterone · ATC G03DA03
3 / 19 countries
- Finlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Hydroxyprogesterone Caproate
- Manufacturer
- AuroMedics Pharma LLC
- Country
- United States (US)
- ATC code
- G03DA03
- ATC class
- Hydroxyprogesterone
- Defined daily dose
- 10 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 2
- ndc1155150311011 VIAL in 1 CARTON (55150-311-01) / 5 mL in 1 VIAL
- ndc1155150311055 VIAL in 1 CARTON (55150-311-05) / 5 mL in 1 VIAL
Regulatory notes
Same class
Other records under G03DA03
Hydroxyprogesterone, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5ea092a7-a499-4432-903a-c727b41834cf GET /v1/drugs/5ea092a7-a499-4432-903a-c727b41834cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "276F2O42F5",
"rxcui": "12488",
"inchikey": "DOMWKUIIPQCAJU-LJHIYBGHSA-N",
"display_name": "HYDROXYPROGESTERONE CAPROATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAMUSCULAR",
"productid": "55150-311_b8f27635-ad16-41d2-a667-eaf51437947a",
"productndc": "55150-311",
"dosage_form": "INJECTION",
"orange_book": {
"appl_no": "211142",
"products": [
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "1250MG/5ML (250MG/ML)",
"product_no": "001",
"approval_date": "May 9, 2019"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "HYDROXYPROGESTERONE CAPROATE",
"proprietary_name": "Hydroxyprogesterone Caproate",
"active_ingred_unit": "mg/5mL",
"application_number": "ANDA211142",
"marketing_category": "ANDA",
"nonproprietary_name": "Hydroxyprogesterone Caproate",
"start_marketing_date": "20190509",
"active_numerator_strength": "1250"
}See everything about hydroxyprogesterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.